Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    1.321 Billion Tourist Nights Recorded in the EU During First Half of 2026

    September 3, 2026

    Over 2,149 Fatalities Linked to Heat in Spain During August, Report Shows

    September 3, 2026

    Guterres Calls for Overhaul of Global Financial System to Address $31 Trillion Debt Challenge

    September 3, 2026
    Trending
    • 1.321 Billion Tourist Nights Recorded in the EU During First Half of 2026
    • Over 2,149 Fatalities Linked to Heat in Spain During August, Report Shows
    • Guterres Calls for Overhaul of Global Financial System to Address $31 Trillion Debt Challenge
    • Euro area inflation reaches 3.3% on August energy gains
    • 8.8 GW of Wind Power Added in H1 2026 Sets New European Record, Says WindEurope
    • Dow Falls 380 Points as Fed Rate Hike Expected Amid Rising Energy Costs
    • Over 6,000 Ebola Cases Reported as UN Urges Swift Global Response to DRC Outbreak
    • 2.5 Million Foreign Tourists Visited Russia in the First Half of 2026, Officials Report
    • Home
    • Contact Us
    Evening Post LondonEvening Post London
    Friday, September 4
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Evening Post LondonEvening Post London
    Home » Breakthrough pacemaker injected via syringe dissolves in body
    Health

    Breakthrough pacemaker injected via syringe dissolves in body

    April 4, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Scientists at Northwestern University have developed the world’s smallest injectable pacemaker, marking a significant advancement in temporary cardiac care, especially for newborns with congenital heart defects. The device, smaller than a grain of rice, is designed to be inserted via a syringe and dissolve harmlessly in the body after use, eliminating the need for surgical removal. Engineered for temporary use, the pacemaker is tailored to provide critical cardiac pacing support during the immediate postoperative recovery phase in infants undergoing heart surgery.

    Breakthrough pacemaker injected via syringe dissolves in body

    According to John A. Rogers, a leading figure in bioelectronics at Northwestern, the device addresses a long-standing need in pediatric cardiology, where the size of existing devices has limited their utility in neonatal patients. The device operates in tandem with a wireless, flexible wearable system that adheres to the patient’s chest. This external unit monitors cardiac activity and, upon detecting irregular rhythms, emits light pulses that non-invasively activate the pacemaker. The light penetrates the skin, breastbone, and surrounding tissue to stimulate the implanted unit.

    All components of the pacemaker are biocompatible and dissolve naturally into the body’s biofluids once they are no longer needed. This eliminates the requirement for a second surgical procedure to extract the device, reducing the overall physical burden on the patient, particularly important in fragile newborns. Igor Efimov, an experimental cardiologist at Northwestern who co-led the project, emphasized the device’s relevance to pediatric care.

    World’s smallest pacemaker dissolves after use

    He noted that approximately 1% of children are born with congenital heart defects and often require temporary pacing for only a few days post-surgery. The new pacemaker offers a non-invasive solution that aligns with this short-term need. The researchers highlighted that multiple units can be deployed simultaneously on the heart to achieve synchronized pacing. Furthermore, the system may be integrated with other implantable devices, such as heart valve replacements, to provide pacing support when complications like heart block arise.

    Because of its size and dissolvable nature, the pacemaker is also suitable for broader medical applications. Rogers indicated the technology could be used to enhance existing implants and support recovery from a range of conditions by providing targeted stimulation. The innovation expands the potential for bioelectronic medicines beyond cardiac care, with possible applications in nerve regeneration, bone healing, wound treatment, and pain management. – By MENA Newswire News Desk.

    Related Posts

    Over 6,000 Ebola Cases Reported as UN Urges Swift Global Response to DRC Outbreak

    September 2, 2026

    Russian Researchers Develop Bioactive Coating to Enhance Titanium Implants with 2026 Findings

    August 19, 2026

    European Union allocates €2.3 million to bolster Africa’s fight against cholera outbreaks

    August 18, 2026

    Phase 1/2 Trial Suggests Guanabenz May Decelerate Childhood VWM Progression by 67%

    August 17, 2026

    Over 11,000 Deaths in Congo’s Ebola Outbreak Expected to Surpass the Deadliest on Record

    August 15, 2026

    Obesity-Related Deaths Account for 8.2% of Belgium’s Mortality in 2022

    August 8, 2026
    Latest News

    1.321 Billion Tourist Nights Recorded in the EU During First Half of 2026

    September 3, 2026

    Over 2,149 Fatalities Linked to Heat in Spain During August, Report Shows

    September 3, 2026

    Guterres Calls for Overhaul of Global Financial System to Address $31 Trillion Debt Challenge

    September 3, 2026

    Euro area inflation reaches 3.3% on August energy gains

    September 3, 2026

    8.8 GW of Wind Power Added in H1 2026 Sets New European Record, Says WindEurope

    September 2, 2026

    Dow Falls 380 Points as Fed Rate Hike Expected Amid Rising Energy Costs

    September 2, 2026

    Over 6,000 Ebola Cases Reported as UN Urges Swift Global Response to DRC Outbreak

    September 2, 2026

    2.5 Million Foreign Tourists Visited Russia in the First Half of 2026, Officials Report

    September 2, 2026
    © 2024 Evening Post London | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.